Investor Stock List
Ranked #7,878 of 8,699 institutional investors

Acuta Capital Partners, LLC

Redwood City, CA

$112M
US stock portfolio at live prices · today −$1.0M (−0.91%)
Live prices, last trade 10:36 AM ET
Value at quarter end (Q3 2026)
$130M
Change from Q2 2026
−$13.9M (−9.69%)
Positions
32 · 9 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $2.0M of stock. $2.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PRAX 23.0%WHWK 12.9%TNGX 8.20%SLN 6.96%FDMT 5.09%
StockSharesValue, live% of portfoliovs Q2 2026
PRAX Praxis Precision Medicines, Inc.84,193$25.8M23.0%Added +2%
WHWK Whitehawk Therapeutics, Inc.4,685,912$14.5M12.9%Unchanged
TNGX Tango Therapeutics, Inc.409,529$9.2M8.20%Added +5%
SLN Silence Therapeutics plc393,583$7.8M6.96%New
FDMT 4D Molecular Therapeutics, Inc.535,109$5.7M5.09%Added +5%
ARGX argenx SE5,558$5.2M4.65%Added +18%
SRZN Surrozen, Inc.152,541$4.5M4.05%Reduced −12%
OCUL Ocular Therapeutix, Inc.574,543$3.3M2.96%Added +8%
AVLN Avalyn Pharma Inc.114,749$3.2M2.87%Reduced −0%
VOGX Vogenx, Inc.213,186$2.7M2.43%New
TSHA Taysha Gene Therapies, Inc.691,843$2.6M2.30%Added +23%
MLTX MoonLake Immunotherapeutics216,568$2.4M2.13%Added +0%
IRLA IRulya Therapeutics Inc.52,918$2.2M1.93%New
LBRX LB Pharmaceuticals Inc52,718$2.1M1.84%Added +82%
IRD Opus Genetics, Inc.514,110$2.0M1.80%New
DRUG Bright Minds Biosciences Inc.93,152$2.0M1.75%Added +0%
AVBP ArriVent BioPharma, Inc.170,893$1.9M1.67%Reduced −22%
AMLX Amylyx Pharmaceuticals, Inc.62,956$1.6M1.46%Reduced −63%
NERV Minerva Neurosciences, Inc.729,500$1.5M1.36%Added +3%
RVMD Revolution Medicines, Inc.8,237$1.4M1.21%New
AVTX Avalo Therapeutics, Inc.186,308$1.3M1.13%Unchanged
UTHR United Therapeutics Corporation2,240$1.2M1.11%Added +1%
DSGN Design Therapeutics, Inc.115,392$1.1M0.96%Reduced −59%
ARTV Artiva Biotherapeutics, Inc.260,416$993K0.89%Unchanged
ERAS Erasca, Inc.67,541$927K0.83%Reduced −75%
CTNM Contineum Therapeutics, Inc.89,826$797K0.71%Added +42%
ANTX AN2 Therapeutics, Inc.142,051$742K0.66%New
ORIC ORIC Pharmaceuticals, Inc.87,918$687K0.61%New
STRO Sutro Biopharma, Inc.25,290$225K0.20%Reduced −91%
EQ Equillium, Inc.183,000$209K0.19%New
CMPX Compass Therapeutics, Inc.251,001$178K0.16%Reduced −58%
STOK Stoke Therapeutics, Inc.5,771$157K0.14%New